TY  - JOUR
AU  - Shao, Ning
AU  - Zhu, Yao
AU  - Ye, Dingwei
PY  - 2018
TI  - Role of polygenic hazard score in prostate-specific antigen (PSA) screening for prostate cancer
JF  - Translational Cancer Research; Vol 7, Supplement 7 (August 28, 2018): Translational Cancer Research
Y2  - 2018
KW  - 
N2  - Prostate cancer (PCa) affects 161,360 people in the USA in 2017 and is responsible for nearly 26,730 deaths, accounting for 19% of all new cases and 8% of all cancer deaths in men (1).  Previous studies suggested that prostate-specific antigen (PSA)-screening could reduce PCa mortality by 27% (2).  However, screening could also bring over-diagnosis, subsequent over-treatment and a higher disease burden.
UR  - https://tcr.amegroups.org/article/view/23126